ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENT
- 1 December 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 318 (8260-8261), 1382-1384
- https://doi.org/10.1016/s0140-6736(81)92800-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death.Circulation, 1980
- PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTIONThe Lancet, 1978
- Effect of propranolol on platelet functionBlood, 1977
- EFFECT OF PROPRANOLOL ON PLATELET-FUNCTION1977
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human PlasmaEuropean Journal of Clinical Investigation, 1975
- Reduction by Propranolol of Myocardial Necrosis following Temporary Coronary Artery Occlusion in DogsCirculation Research, 1973
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962